Togaviridae infectious disease
Togaviridae infectious disease
Explore linked clinical trials. Standard reference: MONDO:000598532 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children. | Alphavirus infectious disease, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, chikungunya, vector-borne disease, viral infectious disease | Active, not recruiting | Phase 3 | 2026-09-30 | NCT07003984 | |
| Evaluation of IXCHIQ® Vaccine Immunogenicity | Alphavirus infectious disease, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, chikungunya, vector-borne disease, viral infectious disease | Not yet recruiting | Phase 2 | 2026-09-29 | NCT07846293 | |
| Real-world Effectiveness, Safety & Immunogenicity of Chikungunya Vaccination: Ambispective Study in Reunion & French Guiana | Alphavirus infectious disease, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, chikungunya, vector-borne disease, viral infectious disease | Recruiting | Phase 4 | 2026-09-28 | NCT06928753 | |
| Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Pediatric Heart Transplantation Patients | Infections, Mononegavirales infectious disease, Paramyxoviridae infectious disease, RNA Virus Infections, Rubivirus Infections, Stomatognathic Diseases, Togaviridae infectious disease, measles, morbillivirus infectious disease, mouth disorder, mumps infectious disease, parotid disorder, parotitis, rubella, salivary gland disorder, viral infectious disease | Recruiting | Phase 4 | 2026-09-24 | NCT07195032 | |
| Against Chikungunya Virus and Neonatal Infection | Alphavirus infectious disease, Encephalopathy, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, brain disorder, central nervous system disorder, chikungunya, nervous system disorder, vector-borne disease, viral infectious disease | Recruiting | Not applicable | 2026-09-15 | NCT07190560 | |
| Smart Analysis and Decision-Making for Emerging Infectious Diseases | Alphavirus infectious disease, COVID-19, Communicable Diseases, Emerging, Coronaviridae Infections, DNA Virus Infections, Disease Attributes, Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, avian influenza, bird disease, chikungunya, dengue disease, infectious disease, influenza, lung disorder, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, pneumonia, respiratory system disorder, respiratory tract infectious disorder, rodent disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease, viral pneumonia | Enrolling by invitation | Not applicable | 2026-08-19 | NCT07678619 | |
| Long-term Follow-up Study to Evaluate Safety and Immunogenicity of CHIKV VLP Single or Booster Vaccination | Alphavirus infectious disease, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, chikungunya, vector-borne disease, viral infectious disease | Active, not recruiting | Phase 3 | 2026-08-07 | NCT06007183 | |
| A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Given to Healthy Children 4 to 6 Years of Age | DNA Virus Infections, Herpesviridae infectious disease, Infections, Mononegavirales infectious disease, Paramyxoviridae infectious disease, RNA Virus Infections, Rubivirus Infections, Stomatognathic Diseases, Togaviridae infectious disease, Varicella Zoster Virus Infection, chickenpox, measles, morbillivirus infectious disease, mouth disorder, mumps infectious disease, parotid disorder, parotitis, rubella, salivary gland disorder, viral infectious disease | Not yet recruiting | Phase 3 | 2026-08-03 | NCT07742644 | |
| Prospective Safety Cohort Study After VLA1553 Vaccination in Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in Brazil | Alphavirus infectious disease, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, chikungunya, vector-borne disease, viral infectious disease | Active, not recruiting | Not stated | 2026-07-21 | NCT07254702 | |
| VLA1553-403 Pregnancy Surveillance Study | Alphavirus infectious disease, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, chikungunya, vector-borne disease, viral infectious disease | Enrolling by invitation | Not stated | 2026-07-20 | NCT07414524 | |
| Observational Study to Assess the Effectiveness of VLA1553 Vaccine in Preventing Chikungunya During a Pilot Vaccination Strategy in Brazil | Alphavirus infectious disease, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, chikungunya, vector-borne disease, viral infectious disease | Enrolling by invitation | Not stated | 2026-07-17 | NCT07347002 | |
| Trial to Evaluate the Immunogenicity and Safety of the Co-administration of Live Attenuated Dengue and Chikungunya Vaccines Compared to Separate Administration in Adults Aged 18 to 59 Years. | Alphavirus infectious disease, Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, chikungunya, dengue disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Not yet recruiting | Phase 3 | 2026-07-16 | NCT06973772 | |
| Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine (VLA1553) | Alphavirus infectious disease, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, chikungunya, vector-borne disease, viral infectious disease | Active, not recruiting | Phase 3 | 2026-07-09 | NCT04838444 | |
| A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age | DNA Virus Infections, Herpesviridae infectious disease, Infections, Mononegavirales infectious disease, Paramyxoviridae infectious disease, RNA Virus Infections, Rubivirus Infections, Stomatognathic Diseases, Togaviridae infectious disease, Varicella Zoster Virus Infection, chickenpox, measles, morbillivirus infectious disease, mouth disorder, mumps infectious disease, parotid disorder, parotitis, rubella, salivary gland disorder, viral infectious disease | Recruiting | Phase 3 | 2026-07-08 | NCT07406360 | |
| An Efficacy, Safety, and Immunogenicity Study of CHIKV VLP Vaccine for the Prevention of Chikungunya Disease in Adolescents and Adults | Alphavirus infectious disease, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, chikungunya, vector-borne disease, viral infectious disease | Recruiting | Phase 3 | 2026-06-29 | NCT07467707 | |
| Effects Of A Rehabilitation Protocol On Muscle Strength, Muscle Fatigue And Postural Control In Post-Dengue And Chikungunya Patients | Alphavirus infectious disease, Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, chikungunya, dengue disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Not yet recruiting | Not applicable | 2026-05-26 | NCT07600879 | |
| A Seamless Phase II/III, Observer-blind, to Evaluate Immunogenicity and Safety of Chikungunya Virus Vaccine in Healthy Subjects 12-65Years of Age. | Alphavirus infectious disease, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, chikungunya, vector-borne disease, viral infectious disease | Recruiting | Phase 2 / Phase 3 | 2026-04-29 | NCT07555392 | |
| A Phase I Study of PepGNP-ChikV in Healthy Volunteers | Alphavirus infectious disease, Disease Attributes, Infections, Mosquito-Borne Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, chikungunya, infectious disease, vector-borne disease, viral infectious disease | Not yet recruiting | Early phase 1 | 2026-04-29 | NCT07394426 | |
| Xpert® Tropical Fever Test on GeneXpert® Edge X System | Alphavirus infectious disease, Bacterial Infections and Mycoses, Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Togaviridae infectious disease, Zika virus infectious disease, arbovirus infection, bacterial infectious disease, chikungunya, dengue disease, gram-negative bacterial infections, leptospirosis, malaria, parasitic infectious disease, protozoa infectious disease, spirochaetales infections, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Enrolling by invitation | Not stated | 2026-04-09 | NCT07520279 | |
| Assessment of Chikungunya Virus Seroprevalence Before VLA1553 Vaccination in the Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in Brazil | Alphavirus infectious disease, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, chikungunya, vector-borne disease, viral infectious disease | Active, not recruiting | Not stated | 2026-02-11 | NCT07163845 | |
| Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective | Adenophorea Infections, Alphavirus infectious disease, Arenaviridae infectious disease, Bacterial Infections and Mycoses, Bunyaviridae infectious disease, Caliciviridae infectious disease, Clostridium infectious disease, DNA Virus Infections, Digestive System Diseases, Disease Attributes, Encephalitis, Arbovirus, Encephalitis, Viral, Enoplea infectious disease, Epstein-Barr virus infection, Euglenozoa Infections, Flaviviridae infectious disease, Flavivirus Infections, Genital Diseases, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Infections, Arenavirus, Japanese encephalitis, Mononegavirales infectious disease, Mosquito-Borne Diseases, Mycoplasma Infections, Mycoplasmatales Infections, Neglected Diseases, Nematoda infectious disease, Neuroinflammatory Diseases, Nipah Virus Infection, Norovirus Infections, Paramyxoviridae infectious disease, Parvoviridae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Picornaviridae infectious disease, Q fever, RNA Virus Infections, Reoviridae infectious disease, Rift valley fever, Rotavirus infection, Rubivirus Infections, Secernentea Infections, Severe Fever with Thrombocytopenia Syndrome, Skin and Connective Tissue Diseases, Spirurida Infections, Stomatognathic Diseases, Togaviridae infectious disease, Trematode Infections, Tumor Virus Infections, Urogenital Diseases, Vaccine-Preventable Diseases, Varicella Zoster Virus Infection, Zika virus infectious disease, Zoonoses, adenoviridae infectious disease, arbovirus infection, bacterial infectious disease, bacterial sexually transmitted disease, bordetellosis, brain disorder, brucellosis, burkholderia infectious disease, central nervous system disorder, central nervous system infectious disorder, chickenpox, chikungunya, chlamydia infectious disease, chlamydiaceae infections, dengue disease, digestive system disorder, encephalitis, enterovirus infectious disease, filarial elephantiasis, filariasis, giardiasis, gram-negative bacterial infections, gram-positive bacterial infections, hantavirus infectious disease, helminthiasis, henipavirus infectious disease, hepatitis, hepatitis A virus infection, hepatitis E virus infection, hepatitis, non-human animal, hepatitis, viral, animal, infectious disease, infectious encephalitis, intestinal disorder, leishmaniasis, leptospirosis, liver disorder, lymphatic system disorder, lymphedema, malaria, measles, melioidosis, meningitis, morbillivirus infectious disease, mouth disorder, mumps infectious disease, nervous system disorder, non-human animal disease, parasitic infectious disease, parasitic intestinal disorder, parasitic skin disorder, parotid disorder, parotitis, pertussis, protozoa infectious disease, respiratory system disorder, respiratory tract infectious disorder, rubella, salivary gland disorder, schistosomiasis, sexually transmitted disease, skin disorder, skin disorder caused by infection, spirochaetales infections, tetanus, tick-borne encephalitis, tick-borne infectious disease, trichuriasis, vector-borne disease, viral hemorrhagic fever, viral hepatitis, viral infection of central nervous system, viral infectious disease, yellow fever | Recruiting | Not stated | 2026-01-22 | NCT07358910 | |
| the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines | Digestive System Diseases, Infections, Mononegavirales infectious disease, Neuroinflammatory Diseases, Paramyxoviridae infectious disease, Picornaviridae infectious disease, RNA Virus Infections, Rubivirus Infections, Stomatognathic Diseases, Togaviridae infectious disease, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, hepatitis, hepatitis A virus infection, liver disorder, measles, morbillivirus infectious disease, mouth disorder, mumps infectious disease, myelitis, nervous system disorder, neuromuscular disease, parotid disorder, parotitis, poliomyelitis, rubella, salivary gland disorder, spinal cord disorder, viral hepatitis, viral infectious disease | Not yet recruiting | Not stated | 2026-01-14 | NCT07338851 | |
| A Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV Vaccine | Alphavirus infectious disease, Encephalitis, Arbovirus, Encephalitis, Viral, Encephalomyelitis, Equine, Infections, Mosquito-Borne Diseases, Neuroinflammatory Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, brain disorder, central nervous system disorder, central nervous system infectious disorder, encephalitis, encephalomyelitis, infectious encephalitis, nervous system disorder, vector-borne disease, viral infection of central nervous system, viral infectious disease | Active, not recruiting | Phase 2 | 2025-10-01 | NCT06899802 | |
| A Clinical Study on the Efficacy and Safety of Reduning Injection in the Treatment of Chikungunya Fever | Alphavirus infectious disease, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, chikungunya, vector-borne disease, viral infectious disease | Not yet recruiting | Not applicable | 2025-08-17 | NCT07126171 | |
| Real-World Study on Chinese Medicine for Treating Chikungunya Fever | Alphavirus infectious disease, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, chikungunya, vector-borne disease, viral infectious disease | Recruiting | Not stated | 2025-08-13 | NCT07120724 |